Literature DB >> 21948930

Aripiprazole-associated rhabdomyolysis in a patient with schizophrenia.

Yung-Fu Wu, Kuo-Yung Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21948930     DOI： 10.1176/jnp.23.3.jnpe51

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  4 in total

Review 1.  Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Authors:  Zacharias G Laoutidis; Kanellos T Kioulos
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

2.  Role of aripiprazole in treatment-resistant schizophrenia.

Authors:  Nilufar Mossaheb; Rainer M Kaufmann
Journal:  Neuropsychiatr Dis Treat       Date:  2012-05-29       Impact factor: 2.570

3.  Tracing diagnosis trajectories over millions of patients reveal an unexpected risk in schizophrenia.

Authors:  Hyojung Paik; Matthew J Kan; Nadav Rappoport; Dexter Hadley; Marina Sirota; Bin Chen; Udi Manber; Seong Beom Cho; Atul J Butte
Journal:  Sci Data       Date:  2019-10-15       Impact factor: 6.444

4.  Acute Dystonia With Rhabdomyolysis Induced by Paliperidone Palmitate: A Rare Adverse Effect.

Authors:  Nishant Allena; Sai Doppalapudi; Sneha Khanal; Steven Tank; Rabih Nasr
Journal:  Cureus       Date:  2022-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.